Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial

BACKGROUND: Visceral leishmaniasis (VL) is a major health problem in developing countries. The untreated disease is fatal, available treatment is expensive and often toxic, and drug resistance is increasing. Improved treatment options are needed. Paromomycin was shown to be an efficacious first-line...

Full description

Saved in:
Bibliographic Details
Main Authors: Hailu, Asrat, Musa, Ahmed, Wasunna, Monique, Balasegaram, Manica, Yifru, Sisay, Mengistu, Getahun, Hurissa, Zewdu, Hailu, Workagegnehu, Weldegebreal, Teklu, Tesfaye, Samson, Makonnen, Eyasu, Khalil, Eltahir, Ahmed, Osama, Fadlalla, Ahmed, El-Hassan, Ahmed, Raheem, Muzamil, Mueller, Marius, Koummuki, Yousif, Rashid, Juma, Mbui, Jane, Mucee, Geoffrey, Njoroge, Simon, Manduku, Veronica, Musibi, Alice, Mutuma, Geoffrey, Kirui, Fredrick, Lodenyo, Hudson, Mutea, Dedan, Kirigi, George, Edwards, Tansy, Smith, Peter, Muthami, Lawrence, Royce, Catherine, Ellis, Sally, Alobo, Moses, Omollo, Raymond, Kesusu, Josephine, Owiti, Rhoda, Kinuthia, John
Format: Artigo
Language:Inglês
Published: Public Library of Science 2010
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964287/
https://ncbi.nlm.nih.gov/pubmed/21049059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000709
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items